ETF Holdings Breakdown of ADMA

News associated with ADMA

Moran Wealth Management LLC Invests $795,000 in ADMA Biologics Inc (NASDAQ:ADMA)

Moran Wealth Management LLC purchased a new position in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 40,056 shares of the biotechnology company’s stock, valued at approximately $795,000. A number of other large investors […] - 2025-06-27 08:14:54

State of Alaska Department of Revenue Sells 3,365 Shares of ADMA Biologics Inc (NASDAQ:ADMA)

State of Alaska Department of Revenue reduced its stake in ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 2.5% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 130,981 shares of the biotechnology company’s stock after selling 3,365 shares during the period. […] - 2025-06-23 07:46:52

ADMA Biologics Inc (NASDAQ:ADMA) Director Sells $3,941,719.76 in Stock

ADMA Biologics Inc (NASDAQ:ADMA – Get Free Report) Director Steve Elms sold 194,749 shares of the business’s stock in a transaction dated Monday, June 16th. The stock was sold at an average price of $20.24, for a total transaction of $3,941,719.76. Following the transaction, the director now owns 87,330 shares in the company, valued at […] - 2025-06-20 08:14:53

Insider Selling: ADMA Biologics Inc (NASDAQ:ADMA) Director Sells 137,931 Shares of Stock

ADMA Biologics Inc (NASDAQ:ADMA – Get Free Report) Director Steve Elms sold 137,931 shares of ADMA Biologics stock in a transaction dated Friday, June 13th. The stock was sold at an average price of $20.82, for a total value of $2,871,723.42. Following the completion of the sale, the director now owns 282,079 shares of the […] - 2025-06-19 08:11:05

ADMA Biologics (NASDAQ:ADMA) Stock Price Down 6.8% on Insider Selling

ADMA Biologics Inc (NASDAQ:ADMA – Get Free Report) shares traded down 6.8% on Tuesday following insider selling activity. The company traded as low as $19.17 and last traded at $19.01. 1,700,847 shares traded hands during trading, a decline of 54% from the average session volume of 3,667,821 shares. The stock had previously closed at $20.40. […] - 2025-06-19 05:13:07

Rhumbline Advisers Buys 1,088 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)

Rhumbline Advisers raised its stake in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 0.2% in the 1st quarter, Holdings Channel reports. The firm owned 622,167 shares of the biotechnology company’s stock after purchasing an additional 1,088 shares during the quarter. Rhumbline Advisers’ holdings in ADMA Biologics were worth $12,344,000 at the end […] - 2025-06-09 08:26:49

Wellington Management Group LLP Sells 13,834 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)

Wellington Management Group LLP lessened its holdings in ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 11.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 105,459 shares of the biotechnology company’s stock after selling 13,834 shares during the quarter. Wellington Management Group […] - 2025-06-06 08:04:51

California State Teachers Retirement System Acquires 8,717 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)

California State Teachers Retirement System grew its position in ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 4.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 217,391 shares of the biotechnology company’s stock after purchasing an additional 8,717 […] - 2025-06-05 08:33:03

B. Riley Wealth Advisors Inc. Cuts Stake in ADMA Biologics, Inc. (NASDAQ:ADMA)

B. Riley Wealth Advisors Inc. lowered its position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 31.8% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 12,614 shares of the biotechnology company’s stock after selling 5,892 shares during the period. B. Riley Wealth Advisors Inc.’s holdings in ADMA Biologics were worth […] - 2025-06-02 08:40:55

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $8.77 Million Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 0.3% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 511,526 shares of the biotechnology company’s stock after acquiring an additional 1,559 shares during […] - 2025-06-01 08:37:02

ADMA Biologics, Inc. (NASDAQ:ADMA) Shares Sold by Tidal Investments LLC

Tidal Investments LLC lessened its position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 20.8% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 30,351 shares of the biotechnology company’s stock after selling 7,983 shares during the quarter. Tidal Investments LLC’s holdings […] - 2025-05-29 08:10:54

Janus Henderson Group PLC Acquires 15,000 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)

Janus Henderson Group PLC raised its holdings in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 16.3% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 107,161 shares of the biotechnology company’s stock after purchasing an additional 15,000 shares during the period. Janus Henderson Group PLC’s […] - 2025-05-22 09:14:47

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $2.56 Million Position in ADMA Biologics, Inc. (NASDAQ:ADMA)

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 7.2% during the 4th quarter, Holdings Channel reports. The firm owned 148,638 shares of the biotechnology company’s stock after purchasing an additional 10,047 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.’s holdings in […] - 2025-05-21 09:14:52

ADMA Biologics (NASDAQ:ADMA) Cut to Sell at StockNews.com

StockNews.com downgraded shares of ADMA Biologics (NASDAQ:ADMA – Free Report) from a hold rating to a sell rating in a research report released on Friday morning. Other equities analysts have also issued reports about the stock. Raymond James boosted their price objective on shares of ADMA Biologics from $25.00 to $32.00 and gave the stock […] - 2025-05-12 05:52:44

33,419 Shares in ADMA Biologics, Inc. (NASDAQ:ADMA) Bought by Mariner LLC

Mariner LLC acquired a new stake in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 33,419 shares of the biotechnology company’s stock, valued at approximately $573,000. A number of other hedge funds have also added to […] - 2025-05-01 08:55:00

Vanguard Group Inc. Boosts Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA)

Vanguard Group Inc. increased its position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 0.4% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 18,198,796 shares of the biotechnology company’s stock after buying an additional 80,302 shares during the quarter. Vanguard […] - 2025-04-04 08:04:57

Corebridge Financial Inc. Lowers Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA)

Corebridge Financial Inc. lowered its holdings in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 7.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 120,299 shares of the biotechnology company’s stock after selling 9,277 shares during the quarter. Corebridge […] - 2025-04-02 08:27:15

KLP Kapitalforvaltning AS Buys New Shares in ADMA Biologics, Inc. (NASDAQ:ADMA)

KLP Kapitalforvaltning AS bought a new stake in ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) in the 4th quarter, Holdings Channel reports. The firm bought 46,300 shares of the biotechnology company’s stock, valued at approximately $794,000. A number of other large investors have also recently added to or reduced their stakes in the company. Lord […] - 2025-04-01 08:14:51

ADMA Biologics, Inc. (NASDAQ:ADMA) Shares Bought by Sei Investments Co.

Sei Investments Co. grew its holdings in ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 147.2% in the 4th quarter, Holdings Channel reports. The institutional investor owned 527,272 shares of the biotechnology company’s stock after buying an additional 314,013 shares during the quarter. Sei Investments Co.’s holdings in ADMA Biologics were worth $9,043,000 at the […] - 2025-03-31 07:36:56

Natixis Advisors LLC Increases Stock Position in ADMA Biologics, Inc. (NASDAQ:ADMA)

Natixis Advisors LLC lifted its position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 69.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 29,153 shares of the biotechnology company’s stock after buying an additional 11,900 shares during […] - 2025-03-28 08:00:59

Signaturefd LLC Cuts Stock Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA)

Signaturefd LLC lessened its holdings in ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 19.5% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 3,768 shares of the biotechnology company’s stock after selling 912 shares during the period. Signaturefd LLC’s holdings in ADMA Biologics were worth $65,000 at […] - 2025-03-25 08:52:48

Cibc World Markets Corp Acquires Shares of 21,076 ADMA Biologics, Inc. (NASDAQ:ADMA)

Cibc World Markets Corp bought a new position in ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 21,076 shares of the biotechnology company’s stock, valued at approximately $361,000. Several other large investors have […] - 2025-03-25 08:08:47

AlphaQuest LLC Buys Shares of 4,924 ADMA Biologics, Inc. (NASDAQ:ADMA)

AlphaQuest LLC bought a new position in ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) in the 4th quarter, HoldingsChannel reports. The fund bought 4,924 shares of the biotechnology company’s stock, valued at approximately $84,000. A number of other institutional investors and hedge funds have also modified their holdings of the business. Larson Financial Group LLC […] - 2025-03-19 08:20:54

Victory Capital Management Inc. Increases Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA)

Victory Capital Management Inc. boosted its position in ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 52.8% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 109,948 shares of the biotechnology company’s stock after purchasing an additional 38,002 shares during the period. Victory Capital Management Inc.’s holdings in ADMA Biologics were worth $1,886,000 […] - 2025-03-18 08:12:52

Arizona State Retirement System Raises Position in ADMA Biologics, Inc. (NASDAQ:ADMA)

Arizona State Retirement System lifted its holdings in ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 6.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 67,581 shares of the biotechnology company’s stock after buying an additional 4,170 shares during the quarter. Arizona […] - 2025-03-14 08:10:52

Oppenheimer & Co. Inc. Reduces Position in ADMA Biologics, Inc. (NASDAQ:ADMA)

Oppenheimer & Co. Inc. cut its holdings in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 59.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 38,416 shares of the biotechnology company’s stock after selling 56,522 shares during the period. […] - 2025-03-07 09:07:02

Cantor Fitzgerald Reaffirms Overweight Rating for ADMA Biologics (NASDAQ:ADMA)

ADMA Biologics (NASDAQ:ADMA – Get Free Report)‘s stock had its “overweight” rating reiterated by analysts at Cantor Fitzgerald in a report released on Tuesday,Benzinga reports. They currently have a $25.00 target price on the biotechnology company’s stock. Cantor Fitzgerald’s price target would suggest a potential upside of 41.40% from the stock’s previous close. Other equities […] - 2025-03-06 07:51:39

Handelsbanken Fonder AB Acquires New Stake in ADMA Biologics, Inc. (NASDAQ:ADMA)

Handelsbanken Fonder AB acquired a new stake in ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 65,700 shares of the biotechnology company’s stock, valued at approximately $1,127,000. Other institutional investors and hedge funds have […] - 2025-02-28 10:40:58

Ieq Capital LLC Takes $352,000 Position in ADMA Biologics, Inc. (NASDAQ:ADMA)

Ieq Capital LLC bought a new position in ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 20,502 shares of the biotechnology company’s stock, valued at approximately $352,000. Other institutional investors and hedge funds also recently added […] - 2025-02-28 10:01:03

ADMA Biologics, Inc. (NASDAQ:ADMA) Shares Sold by State of New Jersey Common Pension Fund D

State of New Jersey Common Pension Fund D trimmed its stake in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 10.4% during the fourth quarter, Holdings Channel reports. The institutional investor owned 101,753 shares of the biotechnology company’s stock after selling 11,854 shares during the period. State of New Jersey Common Pension Fund […] - 2025-02-26 08:30:56

ADMA institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-06-26	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	153,724	USD 2,828,522
2025-06-26	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	47,704	USD 877,754
2025-06-26	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	119,135	USD 2,192,084
2025-06-26	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	119,135	USD 2,192,084
2025-06-26	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	787	USD 14,481
Total =		440,485	USD 8,104,925

Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer